Fusion Antibodies are pleased to be part of the Department for International Trade (DIT) UK pavilion at the BIO International Convention in Philadelphia next month.
Drop by booth #3227 or organize a meeting with our CEO Paul Kerr and Director of Business Development Brett Whitecross about how we can deliver the best possible antibodies to help accelerate your project into the clinic.
The BIO International Convention, being held on June 3-6, celebrates the globally important innovations in biotech that start with one: one meeting, one theory, one trial, one breakthrough.
We’re joining over 16,000 global Business Development leaders from over 7,000 companies to discover the next generation of cutting-edge products, therapies, and cures at events all week long.
Register for this conference at convention.bio.org.